Peripheral blood mononuclear cell mitochondrial enzyme activity is associated with parity and lactation performance in early lactation Holstein dairy cows.

Mitochondria are central to metabolism and are the primary energy producers for all biosynthesis, including lactation. The objectives of this study were to determine if high- and low-producing dairy cows exhibit differences in peripheral blood mononuclear cell mitochondrial enzyme activities of citrate synthase, complex I, complex IV, and complex V during early lactation and, thus, to determine whether those differences were related to differences in lactation performance in the dairy cow. Fifty-six Holstein cows were assigned to 1 of 4 groups: (1) primiparous high, (2) primiparous low, (3) multiparous high, or (4) multiparous low. Primiparous and multiparous cows were analyzed separately. Then, cows were divided into high or low production groups for each production parameter [peak milk, average milk, energy-corrected milk (ECM), fat-corrected milk (FCM), milk lactose, milk fat, milk protein, total solids (TS), solids-not-fat, feed efficiency, and somatic cell count (SCC)]. For all data analysis, production parameters are expressed as yields (kg/d) and SCC (103 cells/mL). High and low production groups were defined by their respective mean production parameters for the 56 cows, with below average cows defined as low and above average cows defined as high. Whole blood samples were collected at one time point, approximately 70 d in milk at 0800 h, and processed for crude mitochondrial extracts from peripheral blood mononuclear cells to determine the activity rates of mitochondrial enzymes. Milk samples were collected 9 times (3 d, 3 times per d) during the week of blood collection and analyzed for major components (fat, protein, lactose, TS, and SCC). Multiparous cows had lower citrate synthase activity than primiparous cows across all production parameters. High-producing cows had greater complex I activity for peak milk, milk yield, ECM, FCM, milk fat, TS, and feed efficiency, and greater complex V activity for ECM, FCM, milk lactose, milk fat, and TS across parities. These findings imply that the most influential respiratory chain enzymes on the level of milk production are those responsible for electron transport chain initialization and ATP production.

Prevalence of complications associated with use of the Henderson equine castrating instrument.

BACKGROUND: Castration is one of the most common surgical procedures performed in the horse. Complication rate and types of complications associated with use of the Henderson equine castrating instrument have not been determined. OBJECTIVE: To determine the complication rate and type of complications encountered when using the Henderson equine castrating instrument in equine ambulatory practice. STUDY DESIGN: Retrospective case series. METHODS: Medical records of horses undergoing routine castration using the Henderson drill were identified and evaluated for the occurrence of complications. The relationship between potential risk factors and complications was examined using basic descriptive statistics and quantified by means of logistic regression. RESULTS: Of 252 horses in the study population, 27 (10.7%) developed a complication after surgery; 25 of which were nonlife-threatening and responded to medical management. Two complications, one each of wound botulism and evisceration, resulted in euthanasia. Age at the time of castration was significantly associated with the occurrence of (P = 0.005, Wilcoxon rank sum test) complications. Compared to younger horses, the odds of having a complication were significantly greater (OR 2.99, 95% CI 1.27-7.0; P = 0.01) for horses of 4 years of age or more. MAIN LIMITATIONS: The retrospective nature of this study. There is also a lack of direct comparison between different castration methods. CONCLUSIONS: The Henderson equine castrating instrument is an acceptable alternative to traditional emasculators. Its use is associated with a low rate of complications (8.3%) in young horses (≤3 years of age) compared to older horses (21.3%) and a very low rate of serious complications (0.8%) in all ages of horses.

Effect of trace mineral source on mineral status and performance of beef steers fed low- or high-sulfur diets.

A 2 × 2 factorial assessed the effect of trace mineral (TM) sources fed within low- or high-S diets on the mineral status and performance of cattle. Angus crossbred steers ( = 48; 6/pen) were blocked by BW (316 ± 16.6 kg), assigned to low-S (0.27%; LS) or high-S (0.54%; HS; added as CaSO) diets, and supplemented TM at 10 mg Cu, 30 mg Zn, and 20 mg Mn/kg DM from hydroxy (HYD; IntelliBond; Micronutrients USA LLC, Indianapolis, IN) or inorganic (sulfates; ING) sources ( = 12 steers/treatment). Steers were fed corn silage and corn-based diets via GrowSafe bunks in the growing period (GP; 84 d) and finishing period (FP; 77 d), respectively. Plasma and liver were collected at trial initiation and end of GP and FP for mineral concentrations. End of GP and FP red blood cell lysate superoxide dismutase (SOD) and Mn-SOD activity and liver glutathione concentrations were measured. Data were used as a 2 × 2 factorial using Proc Mixed of SAS (SAS Inst. Inc., Cary, NC) with initial plasma and liver status analyzed as covariates. High S decreased ( < 0.01) liver Cu and tended ( ≤ 0.10) to decrease plasma Cu concentrations. Liver Cu concentrations were lower in HYD than ING in the FP ( < 0.01). High S decreased ( = 0.04) GP plasma Zn concentrations and tended to decrease ( = 0.10) GP liver Zn. There were GP ( = 0.05) and FP ( = 0.02) S × TM effects for liver Mn concentrations where GP LS-HYD was greater than all other treatments, whereas FP LS-HYD was lower than HS-HYD and LS-ING and FP HS-ING was less than LS-ING. Glutathione, SOD, and Mn-SOD were not different ( ≥ 0.13) in the GP, but S × TM tended to affect FP Mn-SOD ( = 0.10), where LS-HYD tended to be lower than LS-ING. Oxidized glutathione in FP tended to be lower ( = 0.06) for HYD than ING. In the GP, there were S × TM effects on performance where LS-HYD had greater ADG and G:F ( ≤ 0.05) than HS-HYD, whereas LS and HS-ING were intermediate. For FP performance S × TM effects were noted where LS-HYD and HS-ING tended ( = 0.10) to gain more than HS-HYD and HS-HYD had lower G:F ( = 0.04) than HS-ING. There were no effects of S × TM on final BW, DMI, or ADG ( ≥ 0.11); however, HS-HYD had lower G:F than other treatments overall ( = 0.05). High S decreased back fat and yield grade ( = 0.03), and rib eye area was smaller for HYD than ING ( = 0.02). In this study HS decreased markers of Cu and Zn status, and differential effects of HYD vs. ING minerals were noted across dietary phases, although all steers maintained adequate TM status.

The influence of supplemental Zn-amino acid complex and ractopamine hydrochloride feeding duration on growth performance and carcass characteristics of finishing beef cattle.

Previous research indicates that finishing steer ADG and G:F increases linearly with increasing dietary Zn-amino acid complex (ZnAA) supplementation in cattle fed ractopamine hydrochloride (RAC). The objective of this study was to determine the influence of supplemental Zn-amino acid complex on growth performance and carcass characteristics of finishing steers fed RAC for 0, 28, or 42 d prior to harvest. This study was organized as 2 groups (GRP) of steers fed concurrently, for 91 (GRP 1) or 84 d (GRP 2). A total of 324 steers (463 ± 23.4 kg) were fed a corn-based finishing diet supplemented with 60 mg Zn/kg diet DM (as ZnSO). Steers were blocked by weight to pens of 6 steers, and assigned to receive either 0 (CON) or 60 mg supplemental Zn/kg DM from ZnAA ( = 27 pens per treatment). Receiving ZnAA for 49 (GRP 1) or 42 d (GRP 2) prior to start of RAC feeding had no impact on growth of steers ≥ 0.19). Forty-two d prior to harvest, pens were equally assigned within CON or ZnAA treatments to receive RAC at 300 mg∙steer∙d for 0 (NoRAC), 28 (28RAC), or 42 d (42RAC) prior to harvest, creating 6 final treatments ( = 9 pens per treatment). All steers within a GRP were harvested on the same day. Pen was the experimental unit, and the statistical model included the fixed effects of ZnAA, RAC, and block nested within GRP, and the random effect of pen. Ractopamine hydrochloride supplementation increased carcass-adjusted ADG, final BW, HCW, and ribeye area ( ≤ 0.007). There was an effect of ZnAA within 28RAC and 42RAC where carcass-adjusted ADG ( ≤ 0.10), and final BW and HCW ( ≤ 0.05) were greater in ZnAA supplemented vs. CON steers, and 28RAC steers supplemented with ZnAA had improved overall carcass-adjusted G:F relative to CON steers ( = 0.04). However, when steers did not receive RAC there was no effect of ZnAA on final BW, ADG, or HCW ( ≥ 0.78). Additionally, ZnAA supplementation had no effect on the difference in performance between steers supplemented with RAC for 28 vs. 42 d ( 0.21). In conclusion, under the conditions of this study supplemental ZnAA did not prevent the diminished response to RAC as days on RAC increased from 28 to 42. However, there appears to be a synergistic effect of ZnAA on RAC-induced cattle growth, as supplementing 60 mg Zn/kg DM from ZnAA to cattle fed RAC improved overall growth and HCW.

The effects of increasing supplementation of zinc-amino acid complex on growth performance, carcass characteristics, and inflammatory response of beef cattle fed ractopamine hydrochloride.

Forty-two Angus crossbred steers (380 ± 5.3 kg) were enrolled in a finishing study to evaluate the influence of a supplemental Zn amino-acid complex (ZnAA; Availa-Zn) on performance and carcass characteristics of finishing steers in combination with ractopamine hydrochloride (RAC). Steers were stratified by BW into 7 pens of 6 steers each, and individual feed intake was measured. Steers were assigned to 1 of 4 treatments for 86 d (pre-RAC period): a dry-rolled corn-based diet supplemented with 60 mg Zn/kg DM from ZnSO and no supplemental ZnAA (CON; analyzed 88 mg Zn/kg DM; = 6) or CON diet supplemented with 30 (Zn30; = 12), 60 (Zn60; = 12), or 90 (Zn90; = 11) mg Zn/kg DM from ZnAA. Day 86 BW and G:F displayed a quadratic tendency ( = 0.09) with Zn60 steers being greater than the other treatments. Plasma cyclic adenosine monophosphate tended to linearly increase with increasing ZnAA ( = 0.10). On d 88, 6 of 12 steers (one of the 2 pens) receiving supplemental ZnAA was randomly selected to be supplemented with RAC at 300 mg∙steer∙d for the final 28 d of the experiment (RAC period). This created 7 final treatments: CON: no supplemental ZnAA, no RAC ( = 5); Zn30: Zn30, no RAC ( = 5); Zn30R: Zn30 + RAC ( = 6); Zn60: Zn60, no RAC ( = 6); Zn60R: Zn60 + RAC ( = 6); Zn90: Zn90, no RAC ( = 5); and Zn90R: Zn90 + RAC ( = 6). During the RAC period, as supplemental ZnAA increased within RAC-supplemented treatments, there was a linear increase in final BW, ADG, and G:F ( < 0.05). However, there was no effect of supplemental ZnAA on BW, ADG, or G:F during this period in non-RAC fed steers ( ≥ 0.44). Day 111 plasma Cu was increased, plasma Fe decreased, and leukocyte counts and serum interleukin-8 concentrations were greater ( < 0.05) in RAC-fed steers suggesting that RAC may elicit a mild inflammatory response. There was a tendency for increasing Zn supplementation to decrease plasma haptoglobin within RAC-fed steers ( = 0.07), suggesting that Zn may alter the inflammatory response. Overall, Zn60 improved growth performance during the pre-RAC period. Zinc supplemented as ZnAA appears to improve growth in combination with RAC supplementation, suggesting that Zn may enhance or support the biological function of RAC. Additionally, these results indicate that feeding RAC impacts trace mineral status, and potentially causes a non-specific inflammatory response, but further research is required to define this response.

Effect of a multielement trace mineral injection before transit stress on inflammatory response, growth performance, and carcass characteristics of beef steers.

Weaned calves (n = 98; 256 ± 11.5 kg) were used to evaluate the impact of improving trace mineral (TM) status using a multielement TM injection 28 d before transit on markers of inflammatory and stress responses in response to transit and postshipping growth performance. On d 0 of a 28-d preconditioning program, calves received subcutaneous TM injection (MM; n = 48) containing 15, 10, 5, and 60 mg/mL of Cu, Mn, Se, and Zn, respectively, or physiological saline injection (SAL; n = 48). On d 28, steers were weighed, half of the steers from each treatment were transported for a 20-h transit stress period (SHIP; n = 24 per injection treatment), and half of the steers were returned to their pens for 20 h of feed and water restriction without transit (NOSHIP; n = 24 per injection treatment). The SHIP steers were unloaded on d 29 and all steers (SHIP and NOSHIP) were immediately weighed and sorted into new pens (n = 4 steers per pen) for the growing period. At the start of finishing (d 113), steers received a second MM or SAL, resulting in a 2 × 2 × 2 factorial (n = 12 steers per treatment combination). Samples of blood were collected on d 28, 29, and 34 and liver on d 22 and 40. The initial MM increased liver Cu, Se, and Zn concentrations of cattle (P ≤ 0.02) but did not affect ADG during preconditioning (P = 0.89) or BW shrink as a result of transit (P ≥ 0.52). Plasma Fe concentrations were decreased after the transit stress period in SHIP calves (P ≤ 0.05) relative to NOSHIP calves but recovered 5 d after transit, and serum IL-8 concentrations were greater in SAL-SHIP steers than MM-SHIP steers (P = 0.04). Altering TM status through MM caused steers to have lesser ADG (P = 0.03) during the 14-d period after transit (d 29 through 43) but did not affect growth during the growing period (d 5 through 112; P ≥ 0.40). Minimal effects on finishing performance and carcass characteristics were noted, but there was a 3-way interaction (P ≤ 0.02) in which SAL-NOSHIP-MM steers had the greatest yield grade (YG) and smallest ribeye area (REA) and SAL-SHIP-MM steers had the least YG and largest REA. Overall, a MM 28 d before transit or before feed and water restriction did not affect the inflammatory response or plasma TM concentrations but decreased ADG in the 14-d period after transit. Trace mineral injection had limited effects on overall growth performance and carcass characteristics, likely because steer initial TM status was well within the adequate range.

Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals.

Neuronal assemblies within the nervous system produce electrical activity that can be recorded in terms of action potential patterns. Such patterns provide a sensitive endpoint to detect effects of a variety of chemical and physical perturbations. They are a function of synaptic changes and do not necessarily involve structural alterations. In vitro neuronal networks (NNs) grown on micro-electrode arrays (MEAs) respond to neuroactive substances as well as the in vivo brain. As such, they constitute a valuable tool for investigating changes in the electrophysiological activity of the neurons in response to chemical exposures. However, the reproducibility of NN responses to chemical exposure has not been systematically documented. To this purpose six independent laboratories (in Europe and in USA) evaluated the response to the same pharmacological compounds (Fluoxetine, Muscimol, and Verapamil) in primary neuronal cultures. Common standardization principles and acceptance criteria for the quality of the cultures have been established to compare the obtained results. These studies involved more than 100 experiments before the final conclusions have been drawn that MEA technology has a potential for standard in vitro neurotoxicity/neuropharmacology evaluation. The obtained results show good intra- and inter-laboratory reproducibility of the responses. The consistent inhibitory effects of the compounds were observed in all the laboratories with the 50% Inhibiting Concentrations (IC(50)s) ranging from: (mean ± SEM, in µM) 1.53 ± 0.17 to 5.4 ± 0.7 (n = 35) for Fluoxetine, 0.16 ± 0.03 to 0.38 ± 0.16 µM (n = 35) for Muscimol, and 2.68 ± 0.32 to 5.23 ± 1.7 (n = 32) for Verapamil. The outcome of this study indicates that the MEA approach is a robust tool leading to reproducible results. The future direction will be to extend the set of testing compounds and to propose the MEA approach as a standard screen for identification and prioritization of chemicals with neurotoxicity potential.

[Are there gender-related differences in the therapeutic management of patients suffering from inflammatory bowel disease? Subgroup analysis of a prospective multicentre online-based trial]. / Gibt es geschlechtsspezifische Behandlungsunterschiede bei Patienten mit chronisch entzündlichen Darmerkrankungen? Eine Subgruppenanalyse einer prospektiven, multizentrischen, online-basierten Studie.

INTRODUCTION: The most frequently prescribed medications for patients suffering from inflammatory bowel disease (IBD) in the Rhein-Main region of Germany are aminosalicylates and corticosteroids irrespective of the disease activity. In contrast, immunomodulators only play a marginal role. As anti-TNF therapy is very costly, it is prescribed in outpatient services of hospitals rather than in gastroenterological practices. AIM: The aim of this study was to evaluate possible gender-related differences in the therapeutic management of IBD patients treated in the Rhein-Main region of Germany. METHODS: Data records about past medical history, disease status, laboratory values and medical treatment of outpatients of 10 gastroenterological practices and 3 hospitals were collected from November 1st 2005 to July 31st 2007 and analysed with regard to gender-related differences in therapy and disease management. RESULTS: Overall, no statistically significant difference in gender-specific medical treatment could be observed in the study cohort. However, detailed analyses revealed, that 1. women suffering from IBD, who are treated in outpatient services of hospitals, are more often under immunosuppressants, irrespective of disease activity, 2. in gastroenterological practices less than 3 % of patients are prescribed any immunosuppressive therapy (vs. 17 % [men] und 42 % [women] in hospital outpatient services), and 3. anti-TNF therapy is applied more frequently in men as compared to women in hospital outpatient services in both remission and active disease. CONCLUSION: This study discloses the gender-specific differences in the therapeutic management of IBD patients in a congested urban area in Germany. Further studies are required to confirm the tendencies detected.

Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.

OBJECTIVE: The detection of increased fluorine-18 fluorodeoxyglucose (18F-FDG) uptake by positron emission tomography (PET) is based on the enhanced glucose metabolism of tumor cells. Because the detection and staging of hepatocellular carcinoma (HCC) in patients with liver cirrhosis can be difficult, we prospectively evaluated the sensitivity of 18F-FDG PET in 14 consecutive patients with HCC. METHODS: Whole body and regional 18F-FDG PET of the liver were obtained. The results were compared with ultrasonography, contrast-enhanced, helical CT, histological grading, p53 protein expression of HCC, and serum alpha-fetoprotein (AFP) level. RESULTS: In 7 patients PET demonstrated increased tumor 18F-FDG uptake, whereas HCC was not distinguishable from nonmalignant liver tissue in 7 other patients. Hepatic lesions were detected by ultrasonography in all patients, whereas only 11 of 14 HCCs could be identified by CT. In 3 patients extrahepatic spread was demonstrated by 18F-FDG PET. Patients with increased tumor 18F-FDG uptake had significantly larger hepatic lesions and higher serum AFP levels than those with normal 18F-FDG uptake. Lesions could be visualized by 18F-FDG PET in 7 of 8 patients with moderately or poorly differentiated HCC, whereas none of the six well-differentiated tumors was detected. Two patients with strong p53 expression demonstrated increased tumor 18F-FDG uptake and extrahepatic metastases. CONCLUSIONS: The sensitivity of 18F-FDG PET for the imaging of HCC is low. Nevertheless, in patients with moderately or poorly differentiated HCC, tumors >5 cm, or with markedly elevated AFP levels 18F-FDG PET may contribute to an effective noninvasive staging.

Quality of life--theme.

Forensic scientists, as an integral part of the justice system, must move from merely relating their practices to the system to relating their practices to life-the quality life. Life's quality has no single definition. It can include goals to which we aspire or tasks that we must perform. Or, it can be concerned with an ordered preference of things we seek. It can also be determined by the "outcome" of our living or the "process" by which we live. Finally, quality, although it cannot be defined, can be felt. Should we not understand that the quality of life is to be recognized by the true worth of an individual and to be measured by the caring each of us has for our fellow beings as we practice our daily work in the justice system and live our daily lives in the whole human society?

Toxicology and law--1980.

With the great forces of change in the twentieth century--industrialization, bureaucratization, and technologic advances--the efforts to promote health and achieve justice require interdependence and cooperation. The new relationship between toxicology and law sharply reflect this need.